Resolution of migratory pulmonary infiltrates by moxifloxacin in a patient with dual infection of Mycoplasma pneumoniae and Bordetella pertussis;Risoluzione di infiltrati polmonari migranti in un paziente con infezione da Mycoplasma pneumoniae e Bordetella pertussis a seguito di terapia con moxifloxacina

Infezioni in Medicina

Volumn 20, Issue 4, 2012, Pages 288-292

  Kazama, Itsuro ^a   Tamada, Tsutomu ^a   Nakajima, Toshiyuki ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Iwakiri Hospital   (Japan)

Author keywords

Bordetella pertussis; Dual infection; Immunomodulation; Migratory pulmonary infiltrates; Moxifloxacin; Mycoplasma pneumonia

Indexed keywords

C REACTIVE PROTEIN; CLARITHROMYCIN; IMMUNOGLOBULIN M; MINOCYCLINE; MOXIFLOXACIN;

ADULT; ARTICLE; BORDETELLA PERTUSSIS; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; LUNG INFILTRATE; MIXED INFECTION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PERTUSSIS; THORAX RADIOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; FEMALE; HUMANS; PNEUMONIA, MYCOPLASMA; QUINOLINES; WHOOPING COUGH;

EID: 84875885247     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hammerschlag M.R. Mycoplasma pneumoniae infections. Curr. Opin. Infect. Dis. 14, 181-186, 2001.
2. Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin. Infect. Dis. 23, 671-682; quiz 683-4, 1996.
3. Cimolai N., Wensley D., Seear M., Thomas E.T. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin. Infect. Dis. 21, 1182-1185, 1995.
4. Hallander H.O., Gnarpe J., Gnarpe H., Olin P. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand. J. Infect. Dis. 31, 281-286, 1999.
5. Foy H.M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 17, Suppl 1, S37-S46, 1993.
6. Kerr J.R., Matthews R.C. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect Dis. 19, 77-88, 2000.
7. Zouari A., Touati A., Smaoui H., et al. Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports. Infection manca indicazione pagine 2011.
8. Hewlett E. L., Edwards K. M. Clinical practice. Pertussis-not just for kids. N. Engl. J. Med. 352, 1215-1222, 2005.
9. Noble G.R., Bernier R.H., Esber E.C., et al. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA 257, 1351-1356, 1987.
10. Kimura M., Kuno-Sakai H. Developments in pertussis immunisation in Japan. Lancet. 336, 30-32, 1990.
11. Schlesinger C., Koss M.N. The organizing pneumonias: an update and review. Curr. Opin. Pulm. Med. 11, 422-430, 2005.
12. Friedlander A.L., Fessler M.B. A 70-year-old man with migratory pulmonary infiltrates. Chest. 130, 1269-1274, 2006.
13. Stuart P. M. Mycoplasmal induction of cytokine production and major histocompatibility complex expression. Clin. Infect. Dis. 17, Suppl 1, S187-S191, 1993.
14. Baseman J.B., Reddy S.P., Dallo S.F. Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am. J. Respir. Crit. Care Med. 154, S137-S144, 1996.
15. Natori H., Koga T., Fujimoto K., Taguchi J., Kamimura T., Nishimura M. Organizing pneumonia associated with Mycoplasma pneumoniae infection. Jpn. J. Radiol. 28, 688-691, 2010.
16. Llibre J.M., Urban A., Garcia E., Carrasco M.A., Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin. Infect. Dis. 25, 1340-1342, 1997.
17. Mills K.H., Redhead K. Cellular immunity in pertussis. J. Med. Microbiol. 39, 163-164, 1993.
18. Schonwald S., Gunjaca M., Kolacny-Babic L., Car V., Gosev M. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J. Antimicrob. Chemother. 25, Suppl A, 123-126, 1990.
19. Aoyama T., Sunakawa K., Iwata S., Takeuchi Y., Fujii R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J. Pediatr. 129, 761-764, 1996.
20. Balfour J.A., Lamb H.M. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 59, 115-139, 2000.
21. Choi J.H., Song M.J., Kim S.H., et al. Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 47, 3704-3707, 2003.
22. Williams A.C., Galley H.F., Watt A.M., Webster N.R. Differential effects of three antibiotics on T helper cell cytokine expression. J. Antimicrob. Chemother. 56, 502-506, 2005.
23. Kazama I., Maruyama Y., Murata Y., Sano M. Voltage-dependent biphasic effects of chloroquine on delayed rectifier K(+)-channel currents in murine thymocytes. J. Physiol. Sci. 62, 267-274, 2012.
24. Kazama I., Maruyama Y., Murata Y. Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes. Immunopharmacol. Immunotoxicol. 34, 5, 874-878, 2012.
25. Lewis R.S., Cahalan M.D. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 13, 623-653, 1995.